-
Sequential Antigen-loss and Branching Evolution in Lymphoma after Anti-CD19 and Anti-CD20 Targeted T Cell Engaging Immunotherapy
Study
EGAS00001007561
-
Single-cell RNA-seq of peripheral blood mononuclear cells in classic Hodgkin lymphoma
Study
EGAS00001007569
-
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
Study
EGAS00001007585
-
PRADO trial - Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab plus nivolumab in stage III melanoma
Study
EGAS00001007601
-
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
Study
EGAS00001007611
-
NOTCH1 fusion genes in pediatric T-cell lymphoblastic lymphoma hallmark a common high-risk subgroup with blood TARC levels as possible biomarker
Study
EGAS00001007703
-
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Study
EGAS00001007002
-
Genomic and transcriptomic landscape of T-cell lymphoblastic lymphoma compared to T-cell acute lymphoblastic leukemia: similar subtypes and different fusions
Study
EGAS00001007767
-
Pharmacogenomic Analysis Reveals New Therapeutic Options for Pleural Mesothelioma
Study
EGAS00001007866
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998